as on September 18, 2025 at 4:01 pm IST
Market Cap
₹3,566.05 Cr
Return on Equity (ROE)
6.86
PE Ratio (TTM)
28.54
Return on capital employed (ROCE)
7.58
Industry PE ratio
42.21
Beta (LTM)
0P/B Ratio
1.98
Dividend Yield
0PEG Ratio
0.99
Quarterly Earnings Growth YOY
-605.8
EPS (TTM)
19.53
Sector
Pharmaceuticals
Book Value
348.1
Technical Analysis
Bearish
View Technical Analysis
as on September 18, 2025 at 4:01 pm IST
Unichem Laboratories Ltd in the last 5 years
Lowest (-1720.62x)
October 1, 2021
Today (28.54x)
September 17, 2025
Industry (42.21x)
September 17, 2025
Highest (1039.54x)
February 5, 2024
Today’s Price to Earnings Ratio: 28.54x
Compare market cap, revenue, PE, and other key metrics of Unichem Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 3,566.05 | 19.13% | 0.58 | 137 | 2,110 | |
NA | 323.06 | 12.17% | 0.00 | 10 | 150 | |
BUY | 11,519.78 | 5.09% | 0.00 | 485 | 2,386 | |
NA | 1,315.39 | 2290.77% | 0.00 | 9 | 32 | |
NA | 836.28 | -5.52% | 0.61 | 21 | 368 |
Search interest for Unichem Laboratories Ltd Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Unichem Laboratories Ltd.
Unichem Laboratories Ltd’s net profit fell -605.8% since last year same period to ₹-10.47Cr in the Q1 2025-2026. On a quarterly growth basis, Unichem Laboratories Ltd has generated -119.77% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2022, Unichem Laboratories Ltd has declared dividend of ₹4.00 per share on 27 May 2022 - translating a dividend yield of 1.58%.
Read More about DividendsCheck stock indices that include Unichem Laboratories Ltd.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 17.48% to 17.88% in Jun 2025 quarter
Promoter Holding Unchanged
Promoters holdings remained unchanged at 70.22% of holdings in Jun 2025 quarter
FII Holding Unchanged
Foreign Institutions holdings remained unchanged at 0.98% of holdings in Jun 2025 quarter
Against Peers
In the last 1 year, Divis Laboratories Ltd has given 10.7% return, outperforming this stock by 33.1%
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.7% return, outperforming this stock by 109.3%
Price Dip
In the last 6 months, UNICHEMLAB stock has moved down by -20.5%
MF Holding Down
Mutual Funds have decreased holdings from 9.89% to 9.39% in Jun 2025 quarter
Revenue Fall
Revenue is down for the last 2 quarters, 596.43 Cr → 533.42 Cr (in ₹), with an average decrease of 10.6% per quarter
Profit Down
Netprofit is down for the last 3 quarters, 57.85 Cr → -10.47 Cr (in ₹), with an average decrease of 64.1% per quarter
Organisation | Unichem Laboratories Ltd |
Headquarters | Mumbai |
Industry | Pharmaceuticals |
CEO | Prakash A Mody |
E-voting on shares | Click here to vote |
Unichem Laboratories Ltd share price today stands at ₹506.85 as on at the close of the market. Unichem Laboratories Ltd share today touched a day high of ₹515 and a low of ₹503.
Unichem Laboratories Ltd touched a 52 week high of ₹937.95 and a 52 week low of ₹483. Unichem Laboratories Ltd share price today i.e. is closed at ₹506.85, which is -45.96% down from its 52 week high and 4.94% up from its 52 week low.
Unichem Laboratories Ltd market capitalisation is ₹3,566.05 Cr as on .
To buy Unichem Laboratories Ltd shares, you need to follow these steps:
Unichem Laboratories Ltd trading volume is 23.11K as on . This means that 23.11K shares of Unichem Laboratories Ltd were bought and sold on the stock market during today's trading session.